Etiology of the Translocation in ALK-Positive ALCL
The translocation in ALK-positive ALCL is caused by a chromosomal rearrangement, most commonly t(2;5)(p23;q35), which fuses the ALK gene on chromosome 2 with the NPM (nucleophosmin) gene on chromosome 5, occurring in 40-60% of cases. 1
Molecular Mechanism
The fundamental etiology involves a reciprocal chromosomal translocation that creates a chimeric fusion protein. When the ALK gene at 2p23 translocates with NPM at 5q35, it produces the NPM-ALK fusion protein 2, 3. This fusion protein retains the C-terminal portion of ALK, which contains the tyrosine kinase domain, while gaining the N-terminal portion of NPM 4.
Key Pathogenic Features:
- Constitutive activation: The translocation results in constitutive (always-on) activation of the ALK tyrosine kinase, which normally is silent in adult tissues except restricted sites in the nervous system 2, 5
- Oncogenic transformation: The NPM-ALK fusion protein possesses significant oncogenic potential, promoting malignant transformation of T-cells into aggressive lymphoma 3, 6
- Anti-apoptotic function: Biochemical studies suggest NPM-ALK has anti-apoptotic properties that contribute to oncogenesis 2
Variant Translocations
While t(2;5) is the most common, eight variant ALK fusion proteins have been identified 2. Alternative fusion partners include:
- TPM3 (tropomyosin 3)
- TFG (TRK-fused gene)
- ATIC (5' aminoimidazole-4-carboxamide ribonucleotide formyltransferase)
- CLTC (clathrin heavy chain)
- MSN (moesin)
- TPM4 (tropomyosin 4) 5, 4
All variants share the common feature of fusing to the ALK tyrosine kinase domain, resulting in its aberrant constitutive activation.
Clinical Significance
The presence of this translocation defines a distinct clinicopathologic entity that predominantly affects children and young adults 1. The ALK protein overexpression resulting from these translocations can be detected immunohistochemically, which is invaluable for distinguishing ALK-positive from ALK-negative large cell lymphomas 2. Patients with ALK-positive lymphoma produce antibodies to the ALK protein precisely because ALK is normally silent in adult tissues 2.
The translocation can be detected using DNA hybridization techniques or PCR-based methods targeting the NPM-ALK rearrangement 7. Recent molecular understanding has revealed that APE1 can stabilize NPM-ALK fusion protein oligomers, enhancing ALK tumor-promoting activity 6.